全文获取类型
收费全文 | 3015篇 |
免费 | 152篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 65篇 |
妇产科学 | 104篇 |
基础医学 | 317篇 |
口腔科学 | 55篇 |
临床医学 | 303篇 |
内科学 | 923篇 |
皮肤病学 | 54篇 |
神经病学 | 140篇 |
特种医学 | 35篇 |
外科学 | 509篇 |
综合类 | 74篇 |
预防医学 | 202篇 |
眼科学 | 78篇 |
药学 | 177篇 |
中国医学 | 12篇 |
肿瘤学 | 121篇 |
出版年
2023年 | 34篇 |
2022年 | 90篇 |
2021年 | 136篇 |
2020年 | 66篇 |
2019年 | 97篇 |
2018年 | 119篇 |
2017年 | 62篇 |
2016年 | 93篇 |
2015年 | 86篇 |
2014年 | 124篇 |
2013年 | 146篇 |
2012年 | 217篇 |
2011年 | 215篇 |
2010年 | 115篇 |
2009年 | 119篇 |
2008年 | 178篇 |
2007年 | 186篇 |
2006年 | 166篇 |
2005年 | 180篇 |
2004年 | 171篇 |
2003年 | 130篇 |
2002年 | 127篇 |
2001年 | 34篇 |
2000年 | 22篇 |
1999年 | 24篇 |
1998年 | 22篇 |
1997年 | 16篇 |
1996年 | 18篇 |
1995年 | 14篇 |
1994年 | 9篇 |
1993年 | 11篇 |
1992年 | 23篇 |
1991年 | 22篇 |
1990年 | 18篇 |
1989年 | 7篇 |
1988年 | 17篇 |
1987年 | 9篇 |
1986年 | 5篇 |
1985年 | 5篇 |
1984年 | 7篇 |
1983年 | 6篇 |
1982年 | 4篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1977年 | 4篇 |
1975年 | 4篇 |
1973年 | 2篇 |
1968年 | 5篇 |
1967年 | 7篇 |
1966年 | 3篇 |
排序方式: 共有3188条查询结果,搜索用时 0 毫秒
81.
82.
OBJECTIVE: To establish the seroprevalence of infection by Leptospira in an occupational setting in Cordoba. MATERIAL AND METHODS: A cross-sectional study was conducted among 334 farmworkers, butchers, and garbage collectors, to identify the presence of anti-leptospira IgM antibodies, in the Department of Cordoba, Colombia. Stratified sampling proportional to the number of inhabitants and occupation was used to select the sample population (confidence level 99.9%, error 0.5%, prevalence 72%).The SPSS software 11.0 version was used to perform non parametric tests with p < 0.05, as well as odds ratios with confidence intervals. RESULTS: The prevalence of previous infection by Leptospira was high (13.1%). No differences among areas were found, however, higher infection was associated with living in Cienaga de Oro municipality (OR = 3.52 Cl 1.70-7.26) (p = 0,00283). Being a farmer was also a risk factor for infection (OR = 2.04 Cl 1.080-3.85) (p = 0.025), as well as drinking water from a dam (OR = 2.4 CI 1.24-4.70) (p = 0.00787). CONCLUSIONS: The rate of infection is important and a significant public health problem in this area of the Colombian Caribbean coast. 相似文献
83.
Guenther Boden Peter Cheung Sajad Salehi Carol Homko Catherine Loveland-Jones Senthil Jayarajan T. Peter Stein Kevin Jon Williams Ming-Lin Liu Carlos A. Barrero Salim Merali 《Diabetes》2014,63(3):912-922
Endoplasmic reticulum (ER) stress is increased in obesity and is postulated to be a major contributor to many obesity-related pathologies. Little is known about what causes ER stress in obese people. Here, we show that insulin upregulated the unfolded protein response (UPR), an adaptive reaction to ER stress, in vitro in 3T3-L1 adipocytes and in vivo, in subcutaneous (sc) adipose tissue of nondiabetic subjects, where it increased the UPR dose dependently over the entire physiologic insulin range (from ∼35 to ∼1,450 pmol/L). The insulin-induced UPR was not due to increased glucose uptake/metabolism and oxidative stress. It was associated, however, with increased protein synthesis, with accumulation of ubiquitination associated proteins, and with multiple posttranslational protein modifications (acetylations, methylations, nitrosylations, succinylation, and ubiquitinations), some of which are potential causes for ER stress. These results reveal a new physiologic role of insulin and provide a putative mechanism for the development of ER stress in obesity. They may also have clinical and therapeutic implications, e.g., in diabetic patients treated with high doses of insulin. 相似文献
84.
85.
86.
87.
Mei Dai Jingfen Han Salim S. El-Amouri Roscoe O. Brady Dao Pan 《Proceedings of the National Academy of Sciences of the United States of America》2014,111(7):2680-2685
Use of megakaryocytes/platelets for transgene expression may take advantage of their rapid turnover and protective storage in platelets and reduce the risk of activating oncogenes in hematopoietic stem and progenitor cells (HSCs). Here, we show that human megakaryocytic cells could overexpress the lysosomal enzyme, α-l-iduronidase (IDUA), which is deficient in patients with mucopolysaccharidosis type I (MPS I). Upon megakaryocytic differentiation, the amount of released enzyme increased rapidly and steadily by 30-fold. Using a murine MPS I model, we demonstrated that megakaryocyte/platelets were capable of producing, packaging, and storing large amounts of IDUA with proper catalytic activity, lysosomal trafficking, and receptor-mediated uptake. IDUA can be released directly into extracellular space or within microparticles during megakaryocyte maturation or platelet activation, while retaining the capacity for cross-correction in patient’s cells. Gene transfer into 1.7% of HSCs led to long-term normalization of plasma IDUA and preferential distribution of enzyme in liver and spleen with complete metabolic correction in MPS I mice. Detection of GFP (coexpressed with IDUA) in Kupffer cells and hepatocytes suggested liver delivery of platelet-derived IDUA possibly via the clearance pathway for senile platelets. These findings provide proof of concept that cells from megakaryocytic lineage and platelets are capable of generating and storing fully functional lysosomal enzymes and can also lead to efficient delivery of both the enzymes released into the circulation and those protected within platelets/microparticles. This study opens a door for use of the megakaryocytes/platelets as a depot for efficient production, delivery, and effective tissue distribution of lysosomal enzymes.The potential of therapeutic benefits from genetically modified hematopoietic stem cells (HSCs) has been supported in recent gene therapy clinical trials (1, 2). High transgene dosage or selective growth of genetically corrected HSCs appears to be necessary for achieving clinical efficacy. However, genotoxic risk caused by proviral integration-associated oncogenesis is directly concomitant with high numbers of integration events or clonal expansion (3, 4). New approaches are needed to balance the need for high transgene frequency while limiting the associated increased risk of oncogenesis.Platelets are anuclear, secretory particulate entities containing proteins stored in cytoplasmic granules that can be released upon activation (5). Healthy adults produce 2–5 × 1011 platelets daily with a baseline activation rate of 1–5% (6). Use of megakaryocytes (MKs)/platelets for transgene expression may (i) take advantage of this immense cell mass and its rapid turnover (5–9 d); (ii) provide protective storage of the transgene product, which is essential for proteins sensitive to plasma pH; and (iii) continuously dispense proteins via degranulation from platelet activation at baseline (without detectable injury) and/or at sites of vascular injury. Highly efficient protein production and delivery could further reduce the need for high transgene frequency and the risk of activating oncogenes in HSCs and all their progeny. Although using platelets as a delivery system has been demonstrated for the expression of coagulation factors to treat inherited bleeding disorders in mice (7, 8), there has been no report of the feasibility of using MKs/platelets for the generation of nonhematologic proteins.Lysosomal storage diseases (LSDs) are a group of inherited disorders, often affecting multiple organs including the liver and spleen, with a cumulative incidence of 1 in 5,000–7,000 live births (9). Overexpressing lysosomal enzymes in platelets not only can provide the protection of pH-sensitive enzymes and continuous enzyme release via low physiological levels of platelet activation but may also offer the benefit of on-target delivery of platelet-derived enzymes to spleen and liver in the process of platelet clearance (10). However, maintaining proper posttranslational modifications for appropriate lysosomal trafficking and intercellular lysosomal enzyme transfer is essential for metabolic cross correction in treating these multiorgan diseases (11). It is not known whether lysosomal enzymes generated from the MK/platelet lineage would be fully functional and capable of correcting lysosomal deficits in diseased cells.In this study, we used a mouse model of Hurler syndrome, which is the severe form of mucopolysaccharidosis type I (MPS I), one of most common LSDs. It is caused by the deficiency of α-l-iduronidase (IDUA) and consequent accumulation of glycosaminoglycans (GAGs) (12, 13). We show that MKs are capable of producing large amounts of IDUA with proper catalytic function, lysosomal trafficking and receptor-mediated uptake, which could be sorted to and stored within platelets. The IDUA can be released directly into the extracellular space or within microparticles (MPs) during MK maturation or platelet activation, while retaining its ability to cross-correct cells derived from patients with MPS I. 相似文献
88.
Stacey M. Succop Kathleen M. MacQueen Francois van Loggerenberg Nelisile Majola Quarraisha Abdool Karim Salim S. Abdool Karim 《AIDS care》2014,26(12):1521-1525
Disclosure, or open communication, by female microbicide trial participants of their trial participation and use of an investigational HIV prevention drug to a sexual partner may affect participants' trial product usage behavior and contribute to poor adherence. With mixed results from recent microbicide clinical trials being linked to differing participant adherence, insights into the communication dynamics between trial participants and their sexual partners are particularly important. We examined the quantitative association between (1) communication of trial participation to a partner and participant adherence to gel and (2) communication of trial participation to a partner and participant HIV status. An in-depth adherence and product acceptability assessment was administered to the women participating in the CAPRISA 004 trial. Additionally, we collected qualitative data related to communication of trial participation and gel use. Qualitatively, among 165 women who had reported that they had discussed trial participation with others, most (68%) stated that they communicated participation to their sexual partner. Most of the women who had communicated study participation with their partners had received a positive/neutral response from their partner. Some of these women stated that gel use was easy; only a small number said that gel use was difficult. Among women who did not communicate their study participation to their partners, difficulty with gel use was more common and some women stated that they feared communicating their participation. Quantitatively, there was no statistically significant difference in the proportions of women who had communicated study participation to a partner across different adherence levels or HIV status. A deeper knowledge of the dynamics surrounding trial participation communication to male partners will be critical to understanding the spectrum of trial product usage behavior, and ultimately to designing tailored strategies to assist trial participants with product adherence. 相似文献
89.
Mechanical stimulation has been proposed to induce chondrogenesis in cell-seeded scaffolds. However, the effects of mechanical stimuli on engineered cartilage may vary substantially between different scaffolds. This advocates for the need to identify an overarching mechanobiological variable. We hypothesize that energy dissipation of scaffolds subjected to dynamic loading may be used as a mechanobiology variable. The energy dissipation would furnish a general criterion to adjust the mechanical stimulation favoring chondrogenesis in scaffold. Epiphyseal chondro-progenitor cells were then subject to unconfined compression 2 h per day during four days in different scaffolds, which differ only by the level of dissipation they generated while keeping the same loading conditions. Scaffolds with higher dissipation levels upregulated the mRNA of chondrogenic markers. In contrast lower dissipation of scaffolds was associated with downregulation of chondrogenic markers. These results showed that energy dissipation could be considered as a mechanobiology variable in cartilage. This study also indicated that scaffolds with energy dissipation level close to the one of cartilage favors chondrogenic expression when dynamical loading is present. 相似文献
90.
Ismail Bozkurt Yasar Ozturk Guven Guney Burak Arslan Ozlem Gulbahar Yahya Guvenc Salim Senturk Mesut Emre Yaman 《International journal of clinical and experimental pathology》2022,15(1):20
Traumatic brain injury (TBI) continues to be a significant public healthcare concern. Neuroinflammation that occurs in the secondary phase of TBI leads to cognitive and physical dysfunction. A number of therapeutic modalities have been evaluated in an attempt to find a suitable treatment. The only drug approved for the treatment of idiopathic pulmonary fibrosis, pirfenidone, has been evaluated for its antifibrotic, anti-inflammatory, and anti-oxidant properties for various disorders, but this is the first study to examine its effects in an experimental TBI model. Twenty-four Wistar rats were randomly divided into three groups: control, trauma, and pirfenidone. The two latter groups underwent experimental diffuse cortical injury mimicking TBI. Neurological assessment was performed using the Garcia test, histological analysis was performed to examine neuroprotective and anti-inflammatory effects, and biochemical analyses of neuron-specific enolase (NSE), S-100B, caspase-3, and thiobarbituric acid reactive substances were performed. The pirfenidone group had a better Garcia test score (P=0.001), an increased anti-inflammatory effect (P<0.001), and an enhanced neuroprotective effect (P=0.007) along with decreased NSE, S100B, and TBARS levels compared to the trauma group. However, pirfenidone did not show a beneficial effect on caspase-3 levels. Pirfenidone may help decrease mortality and morbidity rates after TBI through its anti-inflammatory and antioxidant effects. 相似文献